Drug Profile
Filgrastim long-acting - Shandong Kexing Bioproducts
Alternative Names: Long-acting G-CSF - Shandong Kexing BioproductsLatest Information Update: 12 Nov 2021
Price :
$50
*
At a glance
- Originator Shandong Kexing Bioproducts Co; Unknown
- Developer Shandong Kexing Bioproducts Co
- Class Chemoprotectants; Granulocyte colony-stimulating factors; Neuroprotectants; Recombinant proteins
- Mechanism of Action Granulocyte colony stimulating factor receptor agonists; Granulocyte colony-stimulating factor replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase Unknown Neutropenia
Most Recent Events
- 01 Jan 2014 Investigation in Neutropenia in China (Parenteral)